DENVILLE, N.J.—Katena Products ("Katena"), a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of Rhein Medical Inc. ("Rhein").
“Having dedicated ourselves to producing the finest quality instruments possible, we are confident that our legacy of quality will continue under Katena.”
Founded nearly 30 years ago by John Bee and Carl Wortham, Rhein Medical shares Katena’s reputation as a provider of premium ophthalmic surgical instruments and devices. Rhein is focused on the anterior segment surgical business, including instruments for cataract and refractive surgery, glaucoma and corneal procedures, and for the ocular surface.
“The acquisition of the Rhein Medical product line is an important addition to Katena’s product portfolio. The combination of these two renowned brands will bring internal synergies as well as offer physicians a more complete resource for handheld instrumentation” said Mark Fletcher, CEO of Katena Products.
John Bee, President of Rhein Medical adds, “Having dedicated ourselves to producing the finest quality instruments possible, we are confident that our legacy of quality will continue under Katena.”
Katena is a recognized worldwide leader in specialty surgical and consumable ophthalmic and optometric products. Katena markets a comprehensive line of surgical instruments, biologics, medical devices and optical lenses to physician offices, hospitals and ambulatory surgery centers through their direct salesforce and to international customers in over 110 countries through an extensive distributor network. Katena continues to strengthen its position in these key markets through organic growth and merger and acquisition strategies. For additional information please visit Katena's About Us page.
Katena Products, Inc. is owned by Audax Private Equity ("Audax"), a Boston-based private equity firm. Since its founding in 1999, Audax Private Equity has been focused on building leading middle market companies. Audax has invested $4 billion in 107 platform and 619 add-on companies. Through its disciplined Buy & Build approach, Audax seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value.
Rhein Medical, Inc. was founded in 1988. The company's product portfolio includes the manufacturing of medical, surgical, ophthalmic, and veterinary instruments and devices.
